Linearity and dissociative antigen noise analyses of competitive microfluidic heterogeneous immunoadsorption

Siwei Zhao1, Wei Wang, Zhihong Li

  • 1National Key Laboratory of Micro/Nano Fabrication Technology, Institute of Microelectronics, Peking University, Beijing 100871, China.

Biomedical Microdevices
|January 26, 2008
PubMed

Insights

Microfluidic heterogeneous immunoadsorption (MHI) shows promise for clinical diagnostics. Diffusion-controlled MHI is recommended for its linear dose-response and perfect assay signals, avoiding antigen noise.

Area of Science:

  • Biomedical Engineering
  • Analytical Chemistry
  • Nanotechnology

Background:

  • Microfluidic heterogeneous immunoadsorption (MHI) is a key on-chip sample preparation technique for clinical diagnostics.
  • Electroosmosis flow (EOF)-based MHI is effective but requires optimization for saturated adsorption performance.

Purpose of the Study:

  • To numerically investigate the adsorption performance of EOF-based MHI under saturated conditions.
  • To analyze the influence of different control modes (flow, surface reaction, diffusion) on MHI performance.

Main Methods:

  • Numerical simulation of competitive MHI under saturated status.
  • Analysis of electroosmosis flow (EOF) dynamics and adsorption kinetics.
  • Characterization of MHI performance across various fluidic control modes.

Main Results:

  • Saturated EOF-based MHI achieves a linear dose-response and perfect assay signals in surface reaction or diffusion control modes.
  • Diffusion control mode effectively eliminates dissociative antigen noise.
  • Diffusion-controlled MHI offers tunable assay times and practical flow velocities for chip applications.

Conclusions:

  • Diffusion-controlled microfluidic heterogeneous immunoadsorption is optimal for sensitive and reliable clinical diagnostics.
  • This method provides a robust platform for on-chip sample preparation, minimizing assay noise and allowing for precise control.